JP Morgan Chase’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02K Buy
+43
New +$637 ﹤0.01% 7324
2024
Q1
Sell
-22
Closed -$822 7404
2023
Q4
$822 Buy
22
+21
+2,100% +$659 ﹤0.01% 6860
2023
Q3
$18 Buy
+1
New +$28 ﹤0.01% 7187
2022
Q2
Sell
-914
Closed -$31K 6458
2022
Q1
$31K Sell
914
-1,548
-63% -$101K ﹤0.01% 5947
2021
Q4
$261K Buy
2,462
+159
+7% +$20.8K ﹤0.01% 5202
2021
Q3
$379K Buy
2,303
+1,767
+330% +$335K ﹤0.01% 4882
2021
Q2
$141K Buy
536
+123
+30% +$38.7K ﹤0.01% 5408
2021
Q1
$167K Buy
413
+12
+3% +$5.36K ﹤0.01% 5215
2020
Q4
$162K Buy
+401
New +$125K ﹤0.01% 4875

Other funds holding BDSX

JP Morgan Chase's BDSX Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Biodesix (BDSX) in Q2 2026: 43 shares worth $1.02K. The stake represents ﹤0.01% of the portfolio and ranks #7324 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in BDSX as recently as Q4 2023.

JP Morgan Chase first reported a position in BDSX in Q4 2020 and has held it in 9 quarters since. The position peaked at $379K in Q3 2021. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • JP Morgan Chase held 43 shares of Biodesix worth $1.02K as of Q2 2026.
  • Biodesix was a new JP Morgan Chase position in Q2 2026.
  • Biodesix made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7324 holding.
  • JP Morgan Chase first reported a position in Biodesix in Q4 2020 and has held it in 9 quarters since.
  • JP Morgan Chase's Biodesix position peaked at $379K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.